The Real World Evidence Programme, which is being led by OLS as part of the UK Government’s Life Sciences Vision and is backed by £10m of government funding, will soon be open for applications.
The aim of the call is to address the evidence gap required for widespread adoption of technologies that have received a recommendation for early use in the NHS from NICE Early Value Assessment (EVA), as well as developing guidance to support innovators to generate quality real world evidence that NICE and commissioners require for adoption and roll-out.
The programme is open to all products with a recommendation for early use in the NHS from NICE EVA, but we particularly encourage submissions aligned with the Life Sciences Vision and its Healthcare Missions. The contracts awarded will be for a maximum of 36 months with no upper limit, subject to justification.
An online briefing event for the call, including the application and assessment process will be held 10:30am-12pm on 23 January 2024.
For further details of the competition, eligibility criteria, and the application and assessment process, please refer to the relevant documents on the NIHR website.
To register for the briefing event, please use this link.
|10:30am-12pm, 23 January 2024
|31 January 2024
|Deadline for applications
|1pm, 27 March 2024
|1 October 2024
For further information please email email@example.com